RCEL compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name

RCELAVITA Medical, Inc.

Mkt capRevenueRevenue

SYKStryker Corp

Mkt capRevenueRevenue

Compare

RCELAVITA Medical, Inc.

SYKStryker Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

RCEL: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

RCEL, solidSYK, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RCEL 5

—Collagen Matrix, Inc. dba Regenity Biosciences ("Regenity")unlistedsupplier

—Stedical Scientific, Inc. ("Stedical")unlistedsupplier

—Collagen Matrix, LLC d/b/a as Regenity Biosciencesunlistedsupplier

—Biomedical Advanced Research and Development Authority ("BARDA")unlistedcustomer

1 more · RCEL chain ›

Shared 0

No shared counterparties.

Only SYK 1

UFPTUFP Technologiessupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

RCELAVITA Medical, Inc.

15.37· pre 16.29· delayed

Mkt cap$25.2MRevenue$22MQ2 FY26Revenue$72MFY25

SYKStryker Corp

339.80· pre 340.48· delayed

Pre-marketNov 5 '26delayed

Mkt cap$129.3BRevenue$6.5BQ3 FY26Revenue$25.1BFY25

Compare

Pre-marketNov 5 '26delayed

RCELAVITA Medical, Inc.

SYKStryker Corp

15.37pre 16.29delayed

Price

339.80pre 340.48delayed

$25.2M

Mkt cap

$129.3B

Q2 FY26$22M

Revenue

$6.5BQ3 FY26

FY25$72M

Revenue

$25.1BFY25

RCEL15.37vsSYK339.80Pre-marketNov 5 '26delayed